BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10470147)

  • 21. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aromatase inhibitors--mechanisms for non-steroidal inhibitors.
    Vanden Bossche HV; Moereels H; Koymans LM
    Breast Cancer Res Treat; 1994; 30(1):43-55. PubMed ID: 7949204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human breast cancer cell line MDA-MB231 produces an aromatase stimulating activity.
    Schmidt M; Löffler G
    Eur J Cell Biol; 1994 Feb; 63(1):96-101. PubMed ID: 8005110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.
    Santen RJ
    Breast Cancer Res Treat; 1981; 1(3):183-202. PubMed ID: 6293627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Aminoglutethimide in the treatment of metastasizing breast carcinoma in old age].
    Gorgone S; Lorenzini C; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
    Chir Ital; 1987 Apr; 39(2):166-75. PubMed ID: 3652316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of the ovary to blockade of aromatization with aminoglutethimide.
    Santen RJ; Samojlik E; Wells SA
    J Clin Endocrinol Metab; 1980 Sep; 51(3):473-7. PubMed ID: 6773974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aromatase activity in lymphocytes of cancer patients and healthy subjects].
    Bershteĭn LM; Kondrat'ev VB; Dil'man VM
    Vopr Onkol; 1990; 36(4):438-40. PubMed ID: 2345991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer.
    Bruning PF; Bonfrer JM; De Jong-Bakker M; Nooyen W
    J Steroid Biochem; 1984 Sep; 21(3):293-8. PubMed ID: 6092781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
    Lønning PE; Dowsett M; Powles TJ
    J Steroid Biochem; 1990 Mar; 35(3-4):355-66. PubMed ID: 2139151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of aminoglutethimide on delta 5-androstenediol metabolism in postmenopausal women with breast cancer.
    Bird CE; Masters V; Sterns EE; Clark AF
    Cancer Res; 1982 Nov; 42(11):4797-800. PubMed ID: 6290048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
    Brodie AM; Santen RJ
    Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of aromatase expression in human tissues.
    Bulun SE; Simpson ER
    Breast Cancer Res Treat; 1994; 30(1):19-29. PubMed ID: 7949202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone therapy of metastatic breast carcinoma].
    Höffken K; Miller AA; Miller B; Becher R; Schmidt CG
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1799-802. PubMed ID: 3933941
    [No Abstract]   [Full Text] [Related]  

  • 34. Aromatase inhibitors: current status.
    Ibrahim NK; Buzdar AU
    Am J Clin Oncol; 1995 Oct; 18(5):407-17. PubMed ID: 7572758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoglutethimide as an inducer of microsomal enzymes. Part 2: Endocrine aspects.
    Lønning PE; Kvinnsland S; Thorsen T; Ekse D
    Breast Cancer Res Treat; 1986; 7 Suppl():S77-82. PubMed ID: 3742065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aminoglutethimide - a new drug for the after care in breast cancer].
    Rabe T; Rabe D; Runnebaum B
    Fortschr Med; 1981 Nov; 99(43):1816-8. PubMed ID: 7308944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction and superinduction of messenger ribonucleic acid specific for aromatase cytochrome P-450 in cultured human skin fibroblasts.
    Berkovitz GD; Chen S; Migeon CJ; Levine MA
    J Clin Endocrinol Metab; 1992 Mar; 74(3):629-34. PubMed ID: 1740498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A site-directed mutagenesis study of human placental aromatase.
    Zhou DJ; Korzekwa KR; Poulos T; Chen SA
    J Biol Chem; 1992 Jan; 267(2):762-8. PubMed ID: 1730667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
    Dowsett M; Santner SJ; Santen RJ; Jeffcoate SL; Smith IE
    Br J Cancer; 1985 Jul; 52(1):31-5. PubMed ID: 4015950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer.
    Murray R; Pitt P
    Breast Cancer Res Treat; 1995 Sep; 35(3):249-53. PubMed ID: 7579495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.